FdaApplication

ANDA 218444

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRICONPHARMA LLC
application_typeANDA
approval_date2025-04-22

Products (3)

ProductActive ingredientStrengthDosage form
SIPONIMODSIPONIMODEQ 2MG BASETABLET;ORAL
SIPONIMODSIPONIMODEQ 0.25MG BASETABLET;ORAL
SIPONIMODSIPONIMODEQ 1MG BASETABLET;ORAL

3 products